Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis

  1. Cortes, J.
  2. Haiderali, A.
  3. Huang, M.
  4. Pan, W.
  5. Schmid, P.
  6. Akers, K.G.
  7. Park, J.E.
  8. Frederickson, A.M.
  9. Fasching, P.A.
  10. O’Shaughnessy, J.
Zeitschrift:
BMC Cancer

ISSN: 1471-2407

Datum der Publikation: 2023

Ausgabe: 23

Nummer: 1

Art: Artikel

DOI: 10.1186/S12885-023-11293-4 GOOGLE SCHOLAR lock_openOpen Access editor